Hanmi Pharm. Co.

128940.KO

188.34 USD

1.22

+0.65%

Overview

Last close

188.34 usd

Market cap

2.39B usd

52 week high

279.43 usd

52 week low

159.67 usd

Target price

253.17 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

2.2723

Price/Book Value

3.1547

Enterprise Value

2.60B usd

EV/Revenue

2.3682

EV/EBITDA

10.6143

Key financials

Revenue TTM

1.05B usd

Gross Profit TTM

573.07M usd

EBITDA TTM

255.49M usd

Earnings per Share

N/A usd

Dividend

0.53 usd

Total assets

1.49B usd

Net debt

N/A usd

About

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.